School of Biosciences
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
Infrastructure for African mines destroying forests at 34 times the rate of the mines themselves
Infrastructure for African mines destroying forests at 34 times the rate of the mines themselves Gaby Clark Scientific Editor Robert Egan Associate Editor Industrial-scale mining in Africa to support global supply chains is leading to unprecedented deforestation across the continent, with 34 hectares of forest removed for every single hectare of active mine site. The scale of mining's deforestation footprint is laid bare in a new University of Sheffield-led study showing that, between 2001...
Longevity Startup Doses First Human in Bid to Reverse Age-Related Sight Loss
A longevity startup has dosed its first patient with a drug to reverse age-related sight loss. Life Biosciences is testing its ER-100 drug, which has been shown to restore vision in monkeys, for safety and side effects in a study of around 18 adults over the next year. It will be targeting patients with glaucoma and NAION, two conditions causing damage to crucial cells in the optic nerve, which transmits visual information from the back of the eye to the brain.
Some drugs 'fail' because of unrealistic testing conditions, scientists discover
Some drugs 'fail' because of unrealistic testing conditions, scientists discover Sadie Harley Scientific Editor Robert Egan Associate Editor A drug once dismissed as ineffective suddenly worked—when scientists tested it under more realistic conditions that mimic the human body. In this surprising new discovery, Northwestern University scientists uncovered a hidden rule of drug behavior. A medicine's effectiveness can change dramatically depending on the conditions inside our cells.